High-dose<i>versus</i>low-dose prednisolone in symptomatic patients with post-COVID-19 diffuse parenchymal lung abnormalities: an open-label, randomised trial (the COLDSTER trial)
Sahajal Dhooria(Post Graduate Institute of Medical Education and Research), Ashutosh N. Aggarwal(All India Institute of Medical Sciences Raipur), Ashish Bhalla(Office of Infectious Diseases), Mandeep Garg(Post Graduate Institute of Medical Education and Research), Valliappan Muthu(Post Graduate Institute of Medical Education and Research), Goverdhan Dutt Puri(Post Graduate Institute of Medical Education and Research), Nidhi Prabhakar(Post Graduate Institute of Medical Education and Research), Siddhant Arora(Post Graduate Institute of Medical Education and Research), Inderpaul Singh Sehgal(Post Graduate Institute of Medical Education and Research), Kuruswamy Thurai Prasad(Post Graduate Institute of Medical Education and Research), Lakshmi Narayana Yaddanapudi(Post Graduate Institute of Medical Education and Research), Ritesh Agarwal(Albert Einstein College of Medicine), Vikas Suri(Post Graduate Institute of Medical Education and Research), Shivani Chaudhary(Post Graduate Institute of Medical Education and Research)
Cited by 57
Related Papers
Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria
|Clinical & Experimental Allergy|2013|895
Health and economic impact of air pollution in the states of India: the Global Burden of Disease Study 2019
|The Lancet Planetary Health|2020|707
Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy
|Hepatology|2007|599
Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): Case Report and Systematic Review of Literature
|Mycopathologia|2021|590
Multicenter Epidemiologic Study of Coronavirus Disease–Associated Mucormycosis, India
|Emerging infectious diseases|2021|479